These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 3023534

  • 1. Establishment of herpes simplex virus latency in vitro with cycloheximide.
    Shiraki K, Rapp F.
    J Gen Virol; 1986 Nov; 67 ( Pt 11)():2497-500. PubMed ID: 3023534
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protein analysis of herpes simplex virus latency in vitro established with cycloheximide.
    Shiraki K, Rapp F.
    Virology; 1989 Sep; 172(1):346-9. PubMed ID: 2549718
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional activity of the herpes simplex virus genome during establishment, maintenance, and reactivation of in vitro virus latency.
    Scheck AC, Wigdahl B, Rapp F.
    Intervirology; 1989 Sep; 30(3):121-36. PubMed ID: 2473963
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Latency in vitro using irradiated herpes simplex virus.
    Nishiyama Y, Rapp F.
    J Gen Virol; 1981 Jan; 52(Pt 1):113-9. PubMed ID: 6267167
    [Abstract] [Full Text] [Related]

  • 7. Cellular DNA synthesis associated with activation of latent herpes simplex virus in cell culture.
    Vonka V, Shiraki K, Wrzos J, Rapp F.
    Intervirology; 1986 Jan; 25(3):144-50. PubMed ID: 3015830
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of hexamethylene bisacetamide and cyclosporin A on recovery of herpes simplex virus type 2 from the in vitro model of latency in a human neuroblastoma cell line.
    Kondo Y, Yura Y, Iga H, Yanagawa T, Yoshida H, Furumoto N, Sato M.
    Cancer Res; 1990 Dec 15; 50(24):7852-7. PubMed ID: 2174735
    [Abstract] [Full Text] [Related]

  • 10. Establishment and biological characterization of an in vitro human cytomegalovirus latency model.
    Tanaka J, Ogura T, Sato H, Hatano M.
    Virology; 1987 Nov 15; 161(1):62-72. PubMed ID: 2823470
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Establishment of latency in vitro by the herpes simplex virus type 1 mutant in1814.
    Harris RA, Preston CM.
    J Gen Virol; 1991 Apr 15; 72 ( Pt 4)():907-13. PubMed ID: 1849973
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Suppression of herpes simplex virus type 1 reactivation from latency by (+-)-9-([(Z)-2-(hydroxymethyl)cyclohexyl]methyl) guanine (L-653,180) in vitro.
    Nsiah YA, Tolman RL, Karkas JD, Rapp F.
    Antimicrob Agents Chemother; 1990 Aug 15; 34(8):1551-5. PubMed ID: 2171423
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. High efficiency latency and activation of herpes simplex virus in human cells.
    Wigdahl BL, Scheck AC, De Clercq E, Rapp F.
    Science; 1982 Sep 17; 217(4565):1145-6. PubMed ID: 6180477
    [Abstract] [Full Text] [Related]

  • 19. Herpes simplex virus latency and reactivation in isolated rat sensory neurons.
    Wigdahl BL, Ziegler RJ, Sneve M, Rapp F.
    Virology; 1983 May 17; 127(1):159-67. PubMed ID: 6305013
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.